Point72 (DIFC)’s Beta Bionics BBNX Stock Holding History

Point72 (DIFC)’s Portfolio BBNX Stock Details BBNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-57,158	Closed	-$700K	–	2186
2025 Q1	$700K	Buy	+57,158	New	+$1.07M	0.03%	556

Other funds holding BBNX

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Wellington Management Group

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

Sands Capital Ventures Arlington, Virginia $421M AUM 26.25% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Point72 (DIFC)'s BBNX Position: Q2 2025 in Review

Point72 (DIFC) sold out of Beta Bionics (BBNX) in Q2 2025, closing a stake of 57,158 shares — an estimated $700K sold.

Point72 (DIFC) first reported a position in BBNX in Q1 2025 and held it in 1 quarter. The position peaked at $700K in Q1 2025. 116 funds tracked by Wall St. Rank hold BBNX as of Q2 2025.

Point72 (DIFC) reported no remaining Beta Bionics position as of Q2 2025 after selling out during the quarter.
Point72 (DIFC) sold 57,158 Beta Bionics shares in Q2 2025, an estimated $700K.
Point72 (DIFC) first reported a position in Beta Bionics in Q1 2025 and held it in 1 quarter.
Point72 (DIFC)'s Beta Bionics position peaked at $700K in Q1 2025.
116 funds tracked by Wall St. Rank held Beta Bionics as of Q2 2025.

Based on Point72 (DIFC)'s 13F filing for Q2 2025, filed 14 Aug 2025.